OBJECTIVE: To examine the influence of viral respiratory infection (VRI) on treatment response in acute asthma in children. STUDY DESIGN: A total of 218 children (mean age, 6.6 years) with acute asthma were recruited. Symptoms were recorded, an asthma severity score was determined, and whenever possible, a per-nasal aspirate was obtained for detection of viruses. Each child's response to inhaled β(2)-agonists was assessed after 6, 12, and 24 hours. RESULTS: The 168 children with VRI symptoms received more treatment with inhaled β(2)-agonists after 6 hours (P = .010), 12 hours (P = .002), and 24 hours (P = .0005) compared with the 50 children without such symptoms. Asthma severity did not differ between the 2 groups. A per-nasal aspirate was obtained from 77% of the children. The most frequently identified virus was rhinovirus (61.4%). Among children with symptoms of a VRI, those with rhinovirus had an impaired response to β(2)-agonists at 6 hours (P = .032). CONCLUSION: Children with acute asthma and symptoms of VRI respond less effectively to β(2)-agonists after 6, 12, or 24 hours and thus may benefit from more intense therapy and monitoring. Crown
OBJECTIVE: To examine the influence of viral respiratory infection (VRI) on treatment response in acute asthma in children. STUDY DESIGN: A total of 218 children (mean age, 6.6 years) with acute asthma were recruited. Symptoms were recorded, an asthma severity score was determined, and whenever possible, a per-nasal aspirate was obtained for detection of viruses. Each child's response to inhaled β(2)-agonists was assessed after 6, 12, and 24 hours. RESULTS: The 168 children with VRI symptoms received more treatment with inhaled β(2)-agonists after 6 hours (P = .010), 12 hours (P = .002), and 24 hours (P = .0005) compared with the 50 children without such symptoms. Asthma severity did not differ between the 2 groups. A per-nasal aspirate was obtained from 77% of the children. The most frequently identified virus was rhinovirus (61.4%). Among children with symptoms of a VRI, those with rhinovirus had an impaired response to β(2)-agonists at 6 hours (P = .032). CONCLUSION:Children with acute asthma and symptoms of VRI respond less effectively to β(2)-agonists after 6, 12, or 24 hours and thus may benefit from more intense therapy and monitoring. Crown
Authors: Jason Girkin; Luke Hatchwell; Paul Foster; Sebastian L Johnston; Nathan Bartlett; Adam Collison; Joerg Mattes Journal: J Immunol Date: 2015-04-06 Impact factor: 5.422
Authors: Emily K Martin; Jane Kuypers; Helen Y Chu; Kirsten Lacombe; Xuan Qin; Bonnie Strelitz; Miranda Bradford; Charla Jones; Eileen J Klein; Janet A Englund Journal: J Clin Virol Date: 2014-11-15 Impact factor: 3.168
Authors: Ina L Lauinger; Jon M Bible; Eugene P Halligan; Harish Bangalore; Olga Tosas; Emma J Aarons; Eithne MacMahon; Cheuk Y W Tong Journal: J Clin Virol Date: 2013-07-22 Impact factor: 3.168
Authors: David Van Ly; Alen Faiz; Christine Jenkins; Ben Crossett; Judith L Black; Brent McParland; Janette K Burgess; Brian G G Oliver Journal: PLoS One Date: 2013-02-15 Impact factor: 3.240
Authors: Denise J McCulloch; Marti H Sears; Jesse T Jacob; G Marshall Lyon; Eileen M Burd; Angela M Caliendo; Charles E Hill; W Allan Nix; M Steven Oberste; Colleen S Kraft Journal: Am J Clin Pathol Date: 2014-08 Impact factor: 2.493
Authors: Shelley A Boeschoten; Corinne M P Buysse; Peter J F M Merkus; Jacob M C van Wijngaarden; Sabien G J Heisterkamp; Johan C de Jongste; Joost van Rosmalen; Suzan C M Cochius-den Otter; Annemie L M Boehmer; Matthijs de Hoog Journal: Pediatr Pulmonol Date: 2018-04-10